The robotic radiosurgery provider will team with TomoTherapy to offer advanced treatments for cancer and other diseases.
By Cecilia Galvin
March 11, 2011
Accuray (Nasdaq: ARAY), a provider of robotic radiosurgery in Sunnyvale, Calif., and TomoTherapy Incorporated (Nasdaq: TOMO), creator of radiation therapy solutions for cancer care in Madison, Wisc., have signed a definitive agreement under which Accuray will acquire TomoTherapy for $4.80 per share in cash and stock, or a total of approximately $277 million.
The transaction combines technologies from two high-growth companies, which currently serve complementary patient populations that are treated by the same medical specialty. The combined company will offer advanced patient-focused technologies for the treatment of cancer and other diseases, ranging from high-precision robotic radiosurgery for early-stage and localized disease…
To continue reading, join today.